Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 136,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 312,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house

Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  2. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  3. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  4. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  5. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  6. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  7. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  8. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  9. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  10. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  11. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  12. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  13. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  14. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  15. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  16. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  17. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  18. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  19. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  20. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  21. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  22. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  23. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  24. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  25. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  26. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  27. Song M, et al. 2018. Nature. 562:423. PubMed
  28. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  29. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  30. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  31. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  32. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  33. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  34. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  35. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  36. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  37. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  38. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  39. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  40. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  41. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  42. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  43. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  44. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  45. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  46. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  47. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  48. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  49. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  50. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  51. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  52. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  53. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  54. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  55. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  56. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  57. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  58. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  59. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  60. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  61. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  62. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  63. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  64. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  65. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  66. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  67. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  68. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  69. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  70. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  71. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  72. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  73. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  74. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  75. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  76. Shi J, et al. 2014. Blood. 123:4015. PubMed
  77. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  78. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  79. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  80. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  81. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  82. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  83. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  84. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  85. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  86. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  87. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  88. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  89. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  90. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  91. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  92. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  93. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  94. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  95. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  96. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  97. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  98. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  99. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  100. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  101. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  102. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  103. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  104. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  105. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  106. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  107. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  108. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  109. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  110. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  111. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  112. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  113. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  114. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  115. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  116. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  117. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  118. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  119. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  120. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  121. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  122. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  123. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  124. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  125. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  126. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  127. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  128. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  129. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  130. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  131. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  132. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  133. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  134. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  135. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  136. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  137. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  138. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  139. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  140. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  141. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  142. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  143. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  144. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  145. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  146. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  147. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  148. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  149. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  150. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  151. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  152. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  153. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  154. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  155. Burns JC, et al. 2020. eLife. 9:00. PubMed
  156. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  157. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  158. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  159. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  160. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  161. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  162. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  163. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  164. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  165. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  166. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  167. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  168. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  169. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  170. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  171. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  172. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  173. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  174. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  175. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  176. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  177. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  178. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  179. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  180. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  181. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  182. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  183. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  184. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  185. Kreutmair S, et al. 2021. Immunity. . PubMed
  186. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account